When you think "U.S. defense contractors," Microsoft (NASDAQ: MSFT ) probably isn't the first name that comes to mind. Nevertheless, Microsoft placed among the winners of one of the more lucrative contracts handed out at the Pentagon last night.
The contract in question, worth as much as $412.2 million to the Redmond, Wash.-based software giant, calls for Microsoft to provide Microsoft Enterprise Technical Support Services necessary to obtain highly trained "Microsoft Blue Badge cardholder support." Receiving these services requires that the DoD obtain access rights to Microsoft's proprietary (closed-source) code, which is licensed under exclusive legal right of Microsoft.�
Thus, Microsoft will be providing the Defense Information Technology Contracting Organization with consulting services that include the provision of software developers and product teams to work on a variety of proprietary Microsoft resources and source code. Also covered by the contract are "Microsoft Premier Support" services such as tools and knowledge bases, problem resolution assistance from product developers, and access to the Microsoft source code when necessary.
Top 10 Supermarket Companies To Invest In Right Now: Luminex Corporation(LMNX)
Luminex Corporation engages in the development, manufacture, and sale of proprietary biological testing technologies and products for the life sciences and diagnostic industries. It offers xMAP technology, an open architecture and multiplexing technology that allows simultaneous analysis of approximately 500 bioassays from a drop of fluid by reading biological tests on the surface of microscopic polystyrene beads called microspheres. The company?s xMAP technology is used in various segments of the life sciences industry, such as the fields of drug discovery and development, clinical diagnostics, genetic analysis, bio-defense, food safety, and biomedical research. It operates in two segments, Technology and Strategic Partnerships; and Assays and Related Products. The Technology and Strategic Partnerships segment provides Luminex LX 100/200 that integrates fluidics, optics, and digital signal processing; FLEXMAP 3D system for use as a general laboratory instrument; and MAGP IX system, a multiplexing analyzer for qualitative and quantitative analysis of proteins and nucleic acids. This segment also offers consumables comprising dyed polystyrene microspheres and sheath fluids. The Assays and Related Products segment develops and sells assays on xMAP technology for use on its installed base of systems. This segment?s products are focused on the human genetics, personalized medicine, and infectious disease segments of the genetic testing market. This segment provides various assay products, which consist of a combination of chemical and biological reagents, and company?s proprietary bead technology used to perform diagnostic and research assays on samples. It serves pharmaceutical companies, clinical laboratories, research institutions, and medical institutions in the United States, Europe, Asia, Canada, and Australia. The company was founded in 1995 and is headquartered in Austin, Texas.
Advisors' Opinion:- [By Sean Williams]
Now what: Normally, a $5 million haircut isn't a big deal. However, if a company is losing money and that $5 million is a clean 14% below its original forecasts, then it's certainly going to garner a negative reaction. It also doesn't help that Natural Molecular Testing Corporation -- that aforementioned "large customer" -- recently entered in a multi-year collaboration with Luminex (NASDAQ: LMNX ) earlier this month, casting a gray cloud over GenMark's future revenue stream with NMTC. Until we get better visibility from GenMark's management team and see the company moving toward profitability, this is a name I'd suggest keeping your distance from.
- [By Seth Jayson]
There's no foolproof way to know the future for Luminex (Nasdaq: LMNX ) or any other company. However, certain clues may help you see potential stumbles before they happen -- and before your stock craters as a result.
- [By Garrett Cook]
In trading on Tuesday, healthcare shares were relative laggards, down on the day by about 0.27 percent. Top losers in the sector includedLuminex (NASDAQ: LMNX), down 11.4 percent, and Sanofi (NYSE: SNY), off 10 percent.
Top 5 Information Technology Companies To Invest In Right Now: Wind Works Power Corp (WWPW)
Wind Works Power Corp. (Wind Works), incorporated on November 20, 2002, the Company intends to develop wind parks. The Company will assemble land packages, secure requisite environmental permitting, provide wind testing by erecting towers to measure wind speed. The Company operates 4.6 megawatts in Germany, in which it has a 49% ownership stake.
The Company�� projects include Ganaraska Wind Park, Settlers Landing, Skyway 126, Ganaraska and Thunder Spirit. The Company focuses to develop 77 megawatts of near-term permitted projects in Germany; 50 megawatts of FIT contracted projects in Ontario; and 320 megawatts of projects in the United States.
Advisors' Opinion:- [By Peter Graham]
Small cap green stocks Geo Finance Corporation (OTCMKTS: GEFI), Dragon Polymers Inc (OTCMKTS: DRAG) and Wind Works Power Corp (OTCMKTS: WWPW) have been getting some extra attention lately from various investment newsletters or investor alerts. However, two of these small cap green stocks have also been the subject of paid promotions or investor relations types of activities. So will these green small cap stocks produce some greenbacks for investors and traders alike? Here is a closer look and a reality check:
Top 5 Information Technology Companies To Invest In Right Now: EDAP TMS S.A.(EDAP)
EDAP TMS S.A., through its subsidiaries, engages in the development, manufacture, and marketing of minimally invasive medical devices primarily for urological diseases. The company operates in two divisions, High Intensity Focused Ultrasound (HIFU), and Urology Devices and Services (UDS). The HIFU division involves in the development, manufacture, and marketing of medical devices based on HIFU technology for the minimally invasive destruction of various types of localized tumors. This division offers Ablatherm, a HIFU-based ultrasound guided device for the treatment of organ-confined prostate cancer. Its HIFU technology allows the surgeon to destroy a defined area of diseased tissue without damaging surrounding tissue and organs. This division also engages in the leasing of equipment, as well as the sale of disposables, spare parts, and maintenance services. This division markets and sells its products through its direct marketing and sales organization, as well as through third-party distributors and agents. The UDS division engages in the development, manufacture, marketing, and servicing of medical devices for the minimally invasive diagnosis or treatment of urological disorders, primarily urinary stones and other clinical indications. This division provides lithotripters for the treatment of urinary tract stones by means of ESWL technology. This division manufactures three models of lithotripters: the Sonolith Praktis, the Sonolith i-move, and the Sonolith i-sys. This division also involves in the leasing of lithotripters, as well as the sale of disposables, spare parts, and maintenance services. This division markets and sells its products through its direct sales and service platform, as well as through agents and third-party distributors. The company?s customers include public and private hospitals, urology clinics, and research institutions worldwide. EDAP TMS S.A. was founded in 1979 and is based in Vaulx-en-Velin, France.
Advisors' Opinion:- [By Bryan Murphy]
This isn't going to be a well-received idea, given how bullish the stock appears to be at this time, but EDAP TMS S.A. (NASDAQ:EDAP) is a sell. Up 82% since the end of May, EDAP is ripe for a pullback, and may have reached the bearish pivot point as of today.
- [By John Udovich]
Laparoscopic surgery or minimally invasive surgery (MIS) is a type of surgical technique where�operations in the abdomen are performed through small incisions while small cap stocks ArthroCare Corporation (NASDAQ: ARTC), EDAP TMS S.A. (NASDAQ: EDAP), SafeStitch Medical Inc (OTCBB: SFES) and Arch Therapeutics Inc (OTCBB: ARTH) are all in some way focused on aiding minimally invasive procedures. According to a 2012 report produced by MedMarket Diligence, LLC, approximately 114 million surgical and procedure-based wounds occur annually worldwide,�including�36 million in the US, and perhaps�up to a quarter of these procedures can be described as laparoscopic in nature.�Moreover,�use of the technique is bound to increase�as�it reduces�pain and hemorrhaging plus leads to a�shorter recovery time.
- [By Bryan Murphy]
Last week, yours truly posed the unpopular (though largely ignored) premise that EDAP TMS S.A. (NASDAQ:EDAP) was poised to tumble. It wasn't anything personal, nor was it a judgment call on the merits of the company. It was simply a trading-based call, observing how the rally EDAP was enjoying at the time appeared to be running out of gas, and there was no floor to halt any pullback.
Top 5 Information Technology Companies To Invest In Right Now: Marketo Inc (MKTO)
Marketo, Inc. (Marketo), incorporated on December 17, 2009, provides cloud-based marketing software platform that enables organizations to engage in modern relationship marketing. The Company�� software platform is designed to enable the execution, management and analytical measurement of marketing activities, helping organizations to acquire new customers. The Company�� platform includes marketing automation, social marketing, sales insight and revenue analytics. Its customer base includes 2,000 customers across a range of industries, including business services, consumer, financial services, healthcare, manufacturing, media, technology and telecommunications. The Company provides its solutions on a subscription basis. Effective December 19, 2013, Marketo Inc acquired Insightera Ltd.
The Company designs, builds and markets a suite of integrated applications to address the needs of modern marketing professionals. The Company�� customers use these applications individually and in combination to streamline and automate marketing processes; develop, retain and extend customer relationships, and measure the positive impact on revenue of marketing programs. Its platform and suite of applications is hosted and delivered over the Web using a cloud-based, or software as a service (SaaS) model, and is built using a multi-tenant architecture. The Company markets and sells its enterprise applications as: Marketo lead management, which includes the core Marketo platform, plus all of the marketing automation capabilities available on the platform; Marketo social marketing, which enables social media campaigns, such as referrals, sweepstakes, and other customer engagement campaigns, and also includes features to add social marketing extensions to traditional marketing campaigns; Marketo sales insight, which provides insights to salespeople about their customers and prospects, and Marketo revenue cycle analytics, which is a suite of analytic tools, analyzers, and ad hoc reporting capabilities taki! ng advantage of its time-series analytics engine.
The Company has built a suite of applications that run on its platform. The applications include marketing automation, social marketing, sales insight and revenue analytics. Marketing automation provides a set of capabilities for marketers to create, automate, and track personalized multi-channel marketing campaigns and relationship-marketing workflows. It includes functionality for marketers to finely segment their prospect and customer database based on collected demographic and behavioral data; generate custom Web pages without programming; send batch and individual personalized marketing messages over email, short message service (SMS) text, and other channels; streamline the entire process of running online (e.g., webinar) and offline (e.g., trade show) marketing events, and to execute multi-step lead nurturing and relationship-marketing campaigns that can run over days, weeks, or months.
Social marketing enables marketers to run social media marketing campaigns, as well as to an increase traditional marketing campaigns with a social marketing aspect in order to amplify marketing messages across social networks. Its solution lets marketers add intelligent social sharing buttons to existing Web content and videos; publish new Facebook pages with the touch of a button; build social engagement applications, such as polls, sweepstakes, and referral offers to engage their audience and promote social cross-posting, and increase existing customer and prospect information with social profiles and sharing behavior.
Sold on a per-seat basis, the Company offers sales insight application to customers utilizing Microsoft dynamics customer relationship management (CRM) or salesforce.com as their CRM system. Revenue Analytics provides a range of ways to help companies understand the correlation between marketing programs and revenue outcomes, and includes: a library of operational reports detailing e-mail and landing page per! formance,! Web activity, and lead performance; intuitive analyzers that show the influence of marketing on individual customer outcomes; analytics that compute and illustrate the impact, effectiveness and return on investment of marketing programs individually and in aggregate, and an ad-hoc report builder for completely customized reports and dashboards.
The Company competes with Act-On, Eloqua, Aprimo, HubSpot, SAS Institute, Unica, ExactTarget, Responsys, Silverpop, Oracle Corporation and SAP AG.
Advisors' Opinion:- [By Roberto Pedone]
Marketo (MKTO) provides a cloud-based marketing software platform that enables organizations to engage in modern relationship marketing. This stock closed up 2.7% at $35.36 in Monday's trading session.
Monday's Volume: 649,000
Three-Month Average Volume: 261,206
Volume % Change: 167%From a technical perspective, MKTO spiked notably higher here right above some near-term support levels at $34 to $33.31 with above-average volume. This stock has been trending sideways inside of a consolidation pattern for the last month and change, with shares moving between $33.31 on the downside and $39.80 on the upside. This move on Monday is starting to push shares of MKTO within range of triggering a big breakout trade above the upper-end of its recent sideways trading chart pattern. That breakout will hit if MKTO manages to take out some key near-term overhead resistance levels at $37.35 to $37.61 and then once it takes out its all-time high at $39.80 with high volume.
Traders should now look for long-biased trades in MKTO as long as it's trending above support at $34 or at $33.31 and then once it sustains a move or close above those breakout levels with volume that's near or above 261,206 shares. If that breakout hits soon, then MKTO will set up to enter new all-time-high territory, which is bullish technical price action. Some possible upside targets off that move are $45 to $50.
- [By David Zeiler]
8. Marketo Inc. (Nasdaq: MKTO): Marketo is a cloud-based marketing software platform, which puts it smack-dab in the heart of one of the hottest sectors in tech. MKTO went public May 17 with an offer price of $13 a share. It rose 64% on its first day, and currently trades at about $33.87, an increase of just over 160.54% from the offer price.
- [By Lee Jackson]
The Lazard trading desk said that active traders may want to look at software stocks that still had unusually high short interest. Those included Concur Technologies (NASDAQ: CNQR), Tangoe Inc. (NASDAQ: TNGO), Jive Software (NASDAQ: JIVE), Marketo Inc. (NASDAQ: MKTO), VeriSign Inc. (NASDAQ: VRSN) and VMware Inc. (NYSE: VMW). Stocks with high short interest can explode to the upside if the company gets back on track and short sellers are forced to cover.
- [By Jon C. Ogg]
Marketo Inc. (NASDAQ: MKTO) was reinstated as Outperform with a $38 price target (versus a $31.49 close) at Credit Suisse.
Nike Inc. (NYSE: NKE) was started as Neutral at UBS.
No comments:
Post a Comment